Moving an object from one location to another—picking and placing—is an ideal application for industrial robots due to the robots’ repeatability, throughput and favorable return on investment. It is ...
“Cross” Season 2 has finally arrived, but it’s been over a year since the hit detective series debuted on Prime Video, so we know you’ll need a bit of a recap. Shannon Witmer (Eloise Mumford) is free, ...
Aldis Hodge is reprising his role as Alex Cross in the Amazon Prime Video series 'Cross' for a second season Keri Anderson/Prime Video Buckle in for another wild ride, because Cross is back! The ...
Season 2 of ‘Cross’ brings the crime thriller back for another high-stakes chapter, with lead Aldis Hodge returning as detective Alex Cross and a mix of familiar faces and exciting new additions ...
The Johannesburg Stock Exchange has listed the Cartesian EasyETFs Balanced Actively Managed ETF on its Main Board, adding to a growing range of active investment products on the exchange. The listing ...
Investors might want to bet on Cartesian Therapeutics, Inc. (RNAC), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
FREDERICK, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...
Factorial’s high-power, lightweight, solid-state batteries have demonstrated real-world performance, including over 1,200 km (745 miles) of driving range in vehicle testing and are being advanced ...
Makeup and beauty are more than just routines—they are powerful forms of self-expression and confidence boosters. Whether you’re a beginner experimenting with your first foundation or a pro mastering ...
As an entry-level subcompact SUV, there's plenty to like about the versatile Toyota Corolla Cross. It’s practical, affordable, and when ordered as a hybrid, capable of delivering real fuel savings.
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases, eliminating the need for preconditioning chemotherapy. Lead candidate Descartes-08 showed promising ...